NEW YORK (GenomeWeb) – Monsanto announced today that it has licensed a CRISPR technology platform from Korean biotechnology company ToolGen with the intention of developing agricultural products.

The global license provides Monsanto with access to ToolGen's comprehensive suite of CRISPR intellectual property for use in plants. The agreement will also expand Monsanto's portfolio of gene editing tools, which the company plans to use to develop improved and sustainable crops.

Specific terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.